<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04299737</url>
  </required_header>
  <id_info>
    <org_study_id>201911589</org_study_id>
    <nct_id>NCT04299737</nct_id>
  </id_info>
  <brief_title>Improving Case Selection for Perioperative S. Aureus Transmission Surveillance to Reduce Surgical Site Infections</brief_title>
  <official_title>Improving Case Selection for Perioperative S. Aureus Transmission Surveillance to Reduce Surgical Site Infections</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Randy Loftus</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>RDB Bioinformatics</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>University of Iowa</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The first patient in the dyad will receive the bundle, which includes patient decolonization
      methods, environmental cleaning in the OR, a hand hygiene system located on the IV pole for
      the anesthesia provider, and intravascular catheter and syringe tip disinfection practices.
      The second patient in the dyad will receive usual care. Both patients will be surveyed by
      obtaining swab samples at the beginning and end of the surgery using the OR PathTrac kits.
      The OR PathTrac software (RDB Bioinformatics, Omaha, NE 68154) uses algorithms to guide
      analysis of the S. aureus isolates and to identify transmission events. Transmission stories
      are processed by the software to generate transmission maps that identify improvement
      successes and failures. It also identifies actionable steps to improve the bundle. The
      perioperative infection control team then uses this information to continually optimize the
      bundle, and the software to measure the effect.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Surgical site infections increase patient morbidity and healthcare costs. The Centers for
      Disease Control and Prevention emphasizes improved basic preventive measures to reduce
      bacterial transmission and infections for patients undergoing surgery.

      Patients undergoing planned oncologic gynecological and plastic surgery will be entered as
      dyads into a worksheet each day that will rank and select the optimal cases. The research
      assistants consent both patients in the dyad to the study while they are in the Day of
      Surgery Admissions area. The first patient in the dyad will receive the bundle, which
      includes patient decolonization methods, environmental cleaning in the OR, a hand hygiene
      system located on the IV pole for the anesthesia provider, and intravascular catheter and
      syringe tip disinfection practices. The second patient in the dyad will receive usual care.
      Both patients will be surveyed by obtaining swab samples at the beginning and end of the
      surgery using the OR PathTrac kits. The OR PathTrac kits are obtained from and analyzed for
      S. aureus isolates by RDB Bioinformatics. The OR PathTrac software (RDB Bioinformatics,
      Omaha, NE 68154) uses algorithms to guide analysis of the S. aureus isolates and to identify
      transmission events. Transmission stories are processed by the software to generate
      transmission maps that identify improvement successes and failures. It also identifies
      actionable steps to improve the bundle. The perioperative infection control team then uses
      this information to continually optimize the bundle, and the software to measure the effect.
    </textblock>
  </detailed_description>
  <overall_status>Active, not recruiting</overall_status>
  <start_date type="Actual">March 9, 2020</start_date>
  <completion_date type="Anticipated">August 1, 2021</completion_date>
  <primary_completion_date type="Anticipated">August 1, 2021</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Time course in S. aureus transmission decline with the intervention.</measure>
    <time_frame>Up to 52 weeks</time_frame>
    <description>S. aureus transmission events by time.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Systematic selection of sequential cases in operating rooms for surveillance to reduce sample size and increase power.</measure>
    <time_frame>Up to 52 weeks</time_frame>
    <description>The outcome is the proportional reduction in the necessary sample size of pairs of cases achieved by systematic selection of sample cases as compared with random selection.</description>
  </secondary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Anticipated">100</enrollment>
  <condition>S. Aureus Transmission</condition>
  <arm_group>
    <arm_group_label>First patient in the case pair</arm_group_label>
    <description>This patient will receive the treatment bundle. S. aureus transmission surveillance will be conducted.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Second patient in the case pair</arm_group_label>
    <description>This patient will receive usual care. S. aureus transmission surveillance will be conducted.</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Treatment Bundle (as defined below)</intervention_name>
    <description>Patient decolonization within one hour of incision, improved environmental cleaning (frequency and quality, including but not limited to targeted use of no touch disinfection with UV-C treatment), provider hand hygiene leveraging proximity, improved catheter disinfection, and surveillance optimization.</description>
    <arm_group_label>First patient in the case pair</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Patients scheduled to undergo oncologic gynecological and plastic surgery requiring
        general/regional anesthesia.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients scheduled to undergo oncologic gynecological and plastic surgery requiring
             general/regional anesthesia.

          -  informed, written consent.

        Exclusion Criteria:

          -  Patients &lt;18 years of age.

          -  Patients scheduled to undergo procedures outside of the surgical service lines listed
             above.

          -  Patients not requiring general or regional anesthesia.

          -  Patients who have a documented allergy or have an allergic reaction to to iodine,
             shellfish, or chlorhexidine.

          -  Patients who have not provided informed, written consent.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>120 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Randy W Loftus, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Iowa</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>University of Iowa</name>
      <address>
        <city>Iowa City</city>
        <state>Iowa</state>
        <zip>52242</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <link>
    <url>http://www.whitehouse.gov/the-press-office/2014/09/18/fact-sheet-obama-administration-takes-actions-combat-antibiotic-resistan</url>
    <description>FACT SHEET: Obama Administration Takes Actions to Combat Antibiotic-Resistant Bacteria. The White House, Office of the Press</description>
  </link>
  <reference>
    <citation>Loftus RW, Brown JR, Koff MD, Reddy S, Heard SO, Patel HM, Fernandez PG, Beach ML, Corwin HL, Jensen JT, Kispert D, Huysman B, Dodds TM, Ruoff KL, Yeager MP. Multiple reservoirs contribute to intraoperative bacterial transmission. Anesth Analg. 2012 Jun;114(6):1236-48. doi: 10.1213/ANE.0b013e31824970a2. Epub 2012 Mar 30.</citation>
    <PMID>22467892</PMID>
  </reference>
  <reference>
    <citation>Dexter F, Ledolter J, Epstein RH, Loftus RW. Importance of operating room case scheduling on analyses of observed reductions in surgical site infections from the purchase and installation of capital equipment in operating rooms. Am J Infect Control. 2020 May;48(5):566-572. doi: 10.1016/j.ajic.2019.08.017. Epub 2019 Oct 19. Review.</citation>
    <PMID>31640892</PMID>
  </reference>
  <reference>
    <citation>Dexter F, Epstein RH, Gostine AL, Penning DH, Loftus RW. Benefit of systematic selection of pairs of cases matched by surgical specialty for surveillance of bacterial transmission in operating rooms. Am J Infect Control. 2020 Jun;48(6):682-687. doi: 10.1016/j.ajic.2019.09.025. Epub 2019 Nov 1.</citation>
    <PMID>31679749</PMID>
  </reference>
  <reference>
    <citation>Loftus RW, Koff MD, Brown JR, Patel HM, Jensen JT, Reddy S, Ruoff KL, Heard SO, Yeager MP, Dodds TM. The epidemiology of Staphylococcus aureus transmission in the anesthesia work area. Anesth Analg. 2015 Apr;120(4):807-18. doi: 10.1213/ANE.0b013e3182a8c16a.</citation>
    <PMID>24937345</PMID>
  </reference>
  <reference>
    <citation>German RR, Lee LM, Horan JM, Milstein RL, Pertowski CA, Waller MN; Guidelines Working Group Centers for Disease Control and Prevention (CDC). Updated guidelines for evaluating public health surveillance systems: recommendations from the Guidelines Working Group. MMWR Recomm Rep. 2001 Jul 27;50(RR-13):1-35; quiz CE1-7.</citation>
    <PMID>18634202</PMID>
  </reference>
  <reference>
    <citation>Rubin RH. Surgical wound infection: epidemiology, pathogenesis, diagnosis and management. BMC Infect Dis. 2006 Nov 27;6:171.</citation>
    <PMID>17129369</PMID>
  </reference>
  <reference>
    <citation>Stulberg JJ, Delaney CP, Neuhauser DV, Aron DC, Fu P, Koroukian SM. Adherence to surgical care improvement project measures and the association with postoperative infections. JAMA. 2010 Jun 23;303(24):2479-85. doi: 10.1001/jama.2010.841.</citation>
    <PMID>20571014</PMID>
  </reference>
  <reference>
    <citation>Wang H, Hong S, Liu Y, Duan Y, Yin H. High inspired oxygen versus low inspired oxygen for reducing surgical site infection: a meta-analysis. Int Wound J. 2017 Feb;14(1):46-52. doi: 10.1111/iwj.12548. Epub 2015 Dec 23. Review.</citation>
    <PMID>26695819</PMID>
  </reference>
  <reference>
    <citation>Koff MD, Loftus RW, Burchman CC, Schwartzman JD, Read ME, Henry ES, Beach ML. Reduction in intraoperative bacterial contamination of peripheral intravenous tubing through the use of a novel device. Anesthesiology. 2009 May;110(5):978-85. doi: 10.1097/ALN.0b013e3181a06ec3.</citation>
    <PMID>19352154</PMID>
  </reference>
  <reference>
    <citation>Loftus RW, Brindeiro BS, Kispert DP, Patel HM, Koff MD, Jensen JT, Dodds TM, Yeager MP, Ruoff KL, Gallagher JD, Beach ML, Brown JR. Reduction in intraoperative bacterial contamination of peripheral intravenous tubing through the use of a passive catheter care system. Anesth Analg. 2012 Dec;115(6):1315-23. doi: 10.1213/ANE.0b013e31826d2aa4. Epub 2012 Nov 9.</citation>
    <PMID>23144441</PMID>
  </reference>
  <reference>
    <citation>Phillips M, Rosenberg A, Shopsin B, Cuff G, Skeete F, Foti A, Kraemer K, Inglima K, Press R, Bosco J. Preventing surgical site infections: a randomized, open-label trial of nasal mupirocin ointment and nasal povidone-iodine solution. Infect Control Hosp Epidemiol. 2014 Jul;35(7):826-32. doi: 10.1086/676872. Epub 2014 May 21.</citation>
    <PMID>24915210</PMID>
  </reference>
  <reference>
    <citation>Loftus RW, Dexter F, Robinson ADM. High-risk Staphylococcus aureus transmission in the operating room: A call for widespread improvements in perioperative hand hygiene and patient decolonization practices. Am J Infect Control. 2018 Oct;46(10):1134-1141. doi: 10.1016/j.ajic.2018.04.211. Epub 2018 Jun 12.</citation>
    <PMID>29907449</PMID>
  </reference>
  <reference>
    <citation>Robinson ADM, Dexter F, Renkor V, Reddy S, Loftus RW. Operating room PathTrac analysis of current intraoperative Staphylococcus aureus transmission dynamics. Am J Infect Control. 2019 Oct;47(10):1240-1247. doi: 10.1016/j.ajic.2019.03.028. Epub 2019 Apr 27.</citation>
    <PMID>31036398</PMID>
  </reference>
  <reference>
    <citation>Durkin MJ, Dicks KV, Baker AW, Lewis SS, Moehring RW, Chen LF, Sexton DJ, Anderson DJ. Seasonal Variation of Common Surgical Site Infections: Does Season Matter? Infect Control Hosp Epidemiol. 2015 Sep;36(9):1011-6. doi: 10.1017/ice.2015.121. Epub 2015 May 26.</citation>
    <PMID>26008876</PMID>
  </reference>
  <reference>
    <citation>Munoz-Price LS, Bowdle A, Johnston BL, Bearman G, Camins BC, Dellinger EP, Geisz-Everson MA, Holzmann-Pazgal G, Murthy R, Pegues D, Prielipp RC, Rubin ZA, Schaffzin J, Yokoe D, Birnbach DJ. Infection prevention in the operating room anesthesia work area. Infect Control Hosp Epidemiol. 2018 Dec 11:1-17. doi: 10.1017/ice.2018.303. [Epub ahead of print] Erratum in: Infect Control Hosp Epidemiol. 2019 Apr;40(4):500.</citation>
    <PMID>30526699</PMID>
  </reference>
  <reference>
    <citation>Schweizer ML, Chiang HY, Septimus E, Moody J, Braun B, Hafner J, Ward MA, Hickok J, Perencevich EN, Diekema DJ, Richards CL, Cavanaugh JE, Perlin JB, Herwaldt LA. Association of a bundled intervention with surgical site infections among patients undergoing cardiac, hip, or knee surgery. JAMA. 2015 Jun 2;313(21):2162-71. doi: 10.1001/jama.2015.5387.</citation>
    <PMID>26034956</PMID>
  </reference>
  <reference>
    <citation>Clark C, Taenzer A, Charette K, Whitty M. Decreasing contamination of the anesthesia environment. Am J Infect Control. 2014 Nov;42(11):1223-5. doi: 10.1016/j.ajic.2014.07.016. Epub 2014 Oct 30.</citation>
    <PMID>25444268</PMID>
  </reference>
  <reference>
    <citation>Wilson AP, Smyth D, Moore G, Singleton J, Jackson R, Gant V, Jeanes A, Shaw S, James E, Cooper B, Kafatos G, Cookson B, Singer M, Bellingan G. The impact of enhanced cleaning within the intensive care unit on contamination of the near-patient environment with hospital pathogens: a randomized crossover study in critical care units in two hospitals. Crit Care Med. 2011 Apr;39(4):651-8. doi: 10.1097/CCM.0b013e318206bc66.</citation>
    <PMID>21242793</PMID>
  </reference>
  <reference>
    <citation>Anderson DJ, Chen LF, Weber DJ, Moehring RW, Lewis SS, Triplett PF, Blocker M, Becherer P, Schwab JC, Knelson LP, Lokhnygina Y, Rutala WA, Kanamori H, Gergen MF, Sexton DJ; CDC Prevention Epicenters Program. Enhanced terminal room disinfection and acquisition and infection caused by multidrug-resistant organisms and Clostridium difficile (the Benefits of Enhanced Terminal Room Disinfection study): a cluster-randomised, multicentre, crossover study. Lancet. 2017 Feb 25;389(10071):805-814. doi: 10.1016/S0140-6736(16)31588-4. Epub 2017 Jan 17.</citation>
    <PMID>28104287</PMID>
  </reference>
  <reference>
    <citation>Loftus RW, Dexter F, Robinson ADM. Methicillin-resistant Staphylococcus aureus has greater risk of transmission in the operating room than methicillin-sensitive S aureus. Am J Infect Control. 2018 May;46(5):520-525. doi: 10.1016/j.ajic.2017.11.002. Epub 2018 Jan 4.</citation>
    <PMID>29307750</PMID>
  </reference>
  <reference>
    <citation>Loftus RW, Dexter F, Robinson ADM, Horswill AR. Desiccation tolerance is associated with Staphylococcus aureus hypertransmissibility, resistance and infection development in the operating room. J Hosp Infect. 2018 Nov;100(3):299-308. doi: 10.1016/j.jhin.2018.06.020. Epub 2018 Jun 30.</citation>
    <PMID>29966756</PMID>
  </reference>
  <verification_date>June 2020</verification_date>
  <study_first_submitted>March 2, 2020</study_first_submitted>
  <study_first_submitted_qc>March 6, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">March 9, 2020</study_first_posted>
  <last_update_submitted>June 19, 2020</last_update_submitted>
  <last_update_submitted_qc>June 19, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">June 23, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor-Investigator</responsible_party_type>
    <investigator_affiliation>University of Iowa</investigator_affiliation>
    <investigator_full_name>Randy Loftus</investigator_full_name>
    <investigator_title>Associate Professor</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Surgical Wound Infection</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Yes</sharing_ipd>
    <ipd_description>Data will be shared upon written request and reviewed by the principal investigator for consideration.</ipd_description>
    <ipd_info_type>Study Protocol</ipd_info_type>
    <ipd_info_type>Statistical Analysis Plan (SAP)</ipd_info_type>
    <ipd_info_type>Informed Consent Form (ICF)</ipd_info_type>
    <ipd_info_type>Clinical Study Report (CSR)</ipd_info_type>
    <ipd_info_type>Analytic Code</ipd_info_type>
    <ipd_time_frame>Upon request and evaluation, if approved by the PI for release, at least one year from publication date.</ipd_time_frame>
    <ipd_access_criteria>Submitted research protocol approved by the principal investigator, Dr. Loftus</ipd_access_criteria>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

